971 resultados para Dan Blickensderfer
Resumo:
This material is based upon work supported by the National Science Foundation through the Florida Coastal Everglades Long-Term Ecological Research program under Cooperative Agreements #DBI-0620409 and #DEB-9910514. This image is made available for non-commercial or educational use only.
Resumo:
This material is based upon work supported by the National Science Foundation through the Florida Coastal Everglades Long-Term Ecological Research program under Cooperative Agreements #DBI-0620409 and #DEB-9910514. This image is made available for non-commercial or educational use only.
Resumo:
This material is based upon work supported by the National Science Foundation through the Florida Coastal Everglades Long-Term Ecological Research program under Cooperative Agreements #DBI-0620409 and #DEB-9910514. This image is made available for non-commercial or educational use only.
Resumo:
Fondo Margaritainés Restrepo
Resumo:
Fondo Margaritainés Restrepo
Resumo:
Se desarrolla un análisis comparativo entre los criptogramas y poemas originales de la novela de Dan Brown, The Da Vinci Code, y su correspondiente traducción al español, realizada por Juanjo Estrella. El trabajo de contraste analiza la traducción de cada uno de los casos y evalúa la labor del traductor, motivando a la vez a que los lectores sean más críticos en su práctica literaria.A comparative analysis is developed here between the original cryptograms and poems found in Dan Brown's novel, The Da Vinci Code, and its Spanish counterpart translated by Juanjo Estrella. This analysis focuses on the translation of each of the cases and the work done by the translator, thus encouraging readers to become more critical in their readings.
Resumo:
Purpose: To evaluate the cardioprotective effects and possible mechanisms of Dan-Yang-Fu-Xin decoction (DYFX) in a rat chronic heart failure (CHF). Methods: A CHF rat model induced by ligation of the left anterior descending coronary artery was used to investigate the cardioprotective effects of DYFX. After intragastric administration for 8 weeks, several functional cardiac indices, including fractional shortening (FS), ejection fraction (EF), heart rate (HR) and cardiac output (CO) were assessed by ultrasound examination. Subsequently, inflammatory markers, viz, interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α), myocardial enzymes, namely, lactate dehydrogenase (LDH) and creatine kinase (CK), were also assessed by enzyme-linked immunosorbent assay (ELISA). Results: Intragastric administration of DYFX (200, 400 and 600 mg/kg) significantly reversed the decrease in body weight and increase in cardiac weight (p < 0.05) induced by CHF. Treatment with DYFX also significantly reversed EF, FS, HR, and CO changes in CHF rats. In addition, DYFX inhibited the two inflammatory cytokines (TNF-α and IL-6) and myocardial enzymes (CK and LDH), suggesting that these effects may include the mechanisms of cardioprotectiion involved in attenuation of CHF. Conclusion: DYFX possesses cardioprotective effects involving CHF. The protective mechanisms may include the suppression of expression of inflammatory mediators and myocardial enzymes.
Resumo:
Title vignette.
Resumo:
From "Tjilik Roman's" series, No. 27. 20 Jun 1950